Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in atopic allergic asthmatic subjects

Journal of Immunology

Volumn 167, Issue 3, 2001, Pages 1734-1739

  Oldfield, W L G ^a   Kay, A B ^a   Larche M ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4;

ALLERGENICITY; ALLERGIC ASTHMA; ARTICLE; CAT; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DANDER; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; PROVOCATION TEST; T LYMPHOCYTE;

EID: 0035423535     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.3.1734     Document Type: Article

References (24)

1. Allergy and allergic diseases: Parts I and II
2. Extrathymic tolerance of mature T cells: Clonal elimination as a consequence of immunity
3. Specific T-cell tolerance may be preceded by a primary response
4. + T cells precedes the development of tolerance in vivo
5. Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d 1
6. IgE-independent MHC-restricted T cell peptide epitope-induced late asthmatic reactions
7. Characterization of the specificity and duration of T cell tolerance to intranasally administered peptides in mice: A role for intramolecular epitope suppression
8. Infectious tolerance
9. + lymphocytes, activated eosinophils, and the magnitude of the allergen-induced late phase cutaneous reaction in man
10. Treatment of cat allergy with T-cell reactive peptides
11. An intracellular calcium increase and protein kinase C activation fail to initiate T cell proliferation in the absence of a costimulatory molecule
12. Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes
13. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses
14. + T cells from allergic individuals
15. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen-stimulated T cell cultures
16. + T cells
17. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
18. + T cell lines
19. 2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro
20. Role of interleukin 10 in specific immunotherapy
21. 2 induces specific T-cell anergy in patients allergic to bee venom
22. A dosing protocol of allergen-derived T cell peptide epitopes for the treatment of allergic disease
23. Induction of non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial
24. Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand